Open access · OA
via OpenAlex
Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2
Wouter De Haes, Lotte Frooninckx, Roel Van Assche, Arne Smolders, Geert Depuydt, JOHAN P. J. BILLEN, Bart P. Braeckman, Liliane Schoofs, Liesbet Temmerman
Proceedings of the National Academy of Sciences · 2014 · ▲ 357 citations
Abstract
The antiglycemic drug metformin, widely prescribed as first-line treatment of type II diabetes mellitus, has lifespan-extending properties. Precisely how this is achieved remains unclear. Via a quantitative proteomics approach using the model organism Caenorhabditis elegans, we gained molecular understanding of the physiological changes elicited by metformin exposure, including changes in branched-chain amino acid catabolism and cuticle maintenance. We show that metformin extends lifespan through the process of mitohormesis and propose a signaling cascade in which metformin-induced production of reactive oxygen species increases overall life expectancy. We further address an important issue in aging research, wherein so far, the key molecular link that translates the reactive oxygen species signal into a prolongevity cue remained elusive. We show that this beneficial signal of the mitohormetic pathway is propagated by the peroxiredoxin PRDX-2. Because of its evolutionary conservation, peroxiredoxin signaling might underlie a general principle of prolongevity signaling.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1073/pnas.1321776111
- Canonical
- link ↗
- Fetched
- 2026-11-07 MST
Cite this
APA
Haes, W.D., Frooninckx, L., Assche, R.V., Smolders, A., Depuydt, G., BILLEN, J.P.J., Braeckman, B.P., Schoofs, L., & Temmerman, L. (2014). Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2. <em>Proceedings of the National Academy of Sciences</em>. https://doi.org/10.1073/pnas.1321776111
Vancouver
Haes WD, Frooninckx L, Assche RV, Smolders A, Depuydt G, BILLEN JPJ, et al. Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2. Proceedings of the National Academy of Sciences. 2014. doi:10.1073/pnas.1321776111.
BibTeX
@article{wouter2014Metfor,
title = {Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2},
author = {Wouter De Haes and Lotte Frooninckx and Roel Van Assche and Arne Smolders and Geert Depuydt and JOHAN P. J. BILLEN and Bart P. Braeckman and Liliane Schoofs and Liesbet Temmerman},
journal = {Proceedings of the National Academy of Sciences},
year = {2014},
doi = {10.1073/pnas.1321776111},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging Cell 2022
Open access · CC-BY
Metformin induces S‐adenosylmethionine restriction to extend the Caenorhabditis elegans healthspan through H3K4me3 modifiers
Frontiers in Pharmacology 2022
Open access · CC-BY
Scorpion Venom Heat–Resistant Synthesized Peptide Increases Stress Resistance and Extends the Lifespan of Caenorhabditis elegans via the Insulin/IGF-1-Like Signal Pathway
Frontiers in Physiology 2012
Open access · CC-BY
Caloric Restriction Extends Yeast Chronological Lifespan by Altering a Pattern of Age-Related Changes in Trehalose Concentration
eLife 2017
Open access · CC-BY
Metformin extends C. elegans lifespan through lysosomal pathway
InTech eBooks 2015
Open access · CC-BY
Antiaging — Effect of Stem Cells on Aging and Stem Cell Aging
bioRxiv (Cold Spring Harbor Laboratory) 2022
Preprint · CC-BY